Spyre Therapeutics, Inc. (SYRE)
34.72
+1.04
(+3.09%)
USD |
NASDAQ |
Dec 10, 15:04
Spyre Therapeutics Market Cap: 2.694B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PTC Therapeutics, Inc. | 6.056B |
| NovaBay Pharmaceuticals, Inc. | 294.87M |
| Palatin Technologies, Inc. | 24.29M |
| Theriva Biologics, Inc. | 7.699M |
| Oragenics, Inc. | 0.7900M |
Market Cap Related Metrics
| Price to Book Value | 5.920 |
| Price | 34.72 |
| Earnings Yield | -6.27% |